(Q24245244)

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

Effects of ethinyl estradiol combined with desogestrel and cyproterone acetate on glucose tolerance and insulin response to an oral glucose load: a one-year randomized, prospective, comparative trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

Effect of seven low-dose combined oral contraceptive preparations on carbohydrate metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Combination contraceptives: effects on weight

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Hormonal versus non-hormonal contraceptives in women with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-Analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Two-year carbohydrate metabolism studies in women using a norethindrone or levonorgestrel triphasic oral contraceptive

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Triphasic Randomized Clinical Trial: Comparison of effects on carbohydrate metabolism

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Serium protein-bound carbohydrate and seromucoid levels during long-acting progestational contraceptive therapy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Phase I clinical trial of two contraceptive preparations. Norethisterone enanthate (NEN) and norethisterone acetate (NET)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Effects of levonorgestrel and desogestrel in low-dose oral contraceptive combinations on serum lipids, apolipoproteins A-I and B and glycosylated proteins

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

A randomized double-blind study of the effects of two low-dose combined oral contraceptives on biochemical aspects. Report from a seven-centred study. WHO Special Programme of Research, Development and Research Training in Human Reproduction. Task f

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic serum parameters: II. Effects upon thyroid function, gastrin, STH, and glucose tolerance

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

A study of adrenal corticol function and its reserve activity in long-acting injectable contraceptive users.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Metabolic effects of three new low-dose pills: a six-month experience

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Comparison of two triphasic contraceptives with different progestogens: effects on metabolism and coagulation proteins

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Progestagen-only oral contraceptives: Comparison of the metabolic effects of levonorgestrel and norethisterone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Lipid and biochemical changes after low-dose oral contraception

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Hemostatic and metabolic effects of lowering the ethinyl-estradiol dose from 30 mcg to 20 mcg in oral contraceptives containing desogestrel.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

The role of body weight in oral contraceptive failure: results from the 1995 national survey of family growth

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Serum resistin levels in women taking combined oral contraceptives containing desogestrel or gestodene

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Effects of two combined oral contraceptives containing ethinyl estradiol 20 microg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Family planning for obese women: challenges and opportunities.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

A multicenter randomized comparison of cycle control and laboratory findings with oral contraceptive agents containing 100 microg levonorgestrel with 20 microg ethinyl estradiol or triphasic norethindrone with ethinyl estradiol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Comparison of the lipoprotein, carbohydrate, and hemostatic effects of phasic oral contraceptives containing desogestrel or levonorgestrel.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Implanon contraceptive implants: effects on carbohydrate metabolism

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

A double-blind comparative study of the effects of a 23-day oral contraceptive regimen with 20 microg ethinyl estradiol and 75 microg gestodene and a 21-day regimen with 30 microg ethinyl estradiol and 75 microg gestodene on hemostatic variables, li

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Metabolic effects of implantable steroid contraceptives for women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 microg ethinyl estradiol and 100 microg levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variables

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Randomized controlled study of the influence of two low estrogen dose oral contraceptives containing gestodene or desogestrel on carbohydrate metabolism

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

The effect of various contraceptive hormonal therapies in women with normal and diabetic oral glucose tolerance test

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Comparative clinical evaluation of the effect on carbohydrate and lipid metabolism of two norethisterone-containing hormonal contraceptives: Mesigyna and TriNovum.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Metabolic and fibrinolytic response to changed insulin sensitivity in users of oral contraceptives.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Carbohydrate metabolism in women who used oral contraceptives containing levonorgestrel or desogestrel: a 6-month prospective study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Allocation concealment in randomised trials: defending against deciphering

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Sample size slippages in randomised trials: exclusions and the lost and wayward

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Preventing chronic diseases: how many lives can we save?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Reflections of a whistle-blower

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

A comparative study on the effects of a contraceptive vaginal ring NuvaRing and an oral contraceptive on carbohydrate metabolism and adrenal and thyroid function

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

New progestagens for contraceptive use.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

A study of the interactive effects of oral contraceptive use and dietary fat intake on blood pressure, cardiovascular reactivity and glucose tolerance in normotensive women.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Ethnic comparisons of obesity in the Asia-Pacific region: protocol for a collaborative overview of cross-sectional studies.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

The insulin resistance syndrome: definition and dietary approaches to treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Effects of injectable or implantable progestin-only contraceptives on insulin-glucose metabolism and diabetes risk.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

Randomized prospective studies on metabolic effects of oral contraceptives

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

A randomized cross-over study comparing pharmacodynamic and metabolic variables of a new combiphasic and a well-established triphasic oral contraceptive.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

A comparative study of the effects of gestodene 60 microg/ethinylestradiol 15 microg and desogestrel 150 microg/ethinylestradiol 20 microg on hemostatic balance, blood lipid levels and carbohydrate metabolism.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021

A comparative analysis of three methods of contraception: Effects on blood glucose and serum lipid profiles.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB2

7 January 2021